Bioquell PLC (LSE:BQE) - Overview

Stock Report

Bioquell PLC BQE

Last Price
GBX137.50

Day Change
-1.00|-0.72%

As of 02/12/2016
16:00:03 GMT | GBX
Minimum 15 Minutes Delay.

Last Close138.50p
Day Range135.00 - 137.50
Mkt Cap31.54Mil
52-Wk Range119.50 - 178.00
Yield %2.40
ISINGB0004992003
Volume1,880,476
P/E60.95
P/S2.18
P/CF11.00

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
Bioquell PLC5.77 
FTSE 100 TR GBP-1.21
 
Financials
201320142015
More ...
Income Statement
Turnover44.6427.2726.88
Operating Profit2.90-4.680.55
Net Profit3.05-3.780.64
Reported EPS7.20-8.901.50
Balance Sheet
Current Assets16.1917.9956.55
Non Current Assets28.9724.1514.31
Total Assets45.1642.1370.86
Current Liabilities7.757.654.59
Total Liabilities11.9011.085.94
Total Equity33.2631.0664.92
Cash Flow
Operating Cash Flow7.483.885.25
Net Change in Cash0.57-0.7144.72
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20161.394.1182.3033.430.411.991.45
20171.867.2275.4219.060.252.772.01
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
21/06/2016SaleMr. Christopher Mills200.006,305,00012,610,000.00
21/06/2016SaleMr. Simon Constantine200.00235,000470,000.00
21/06/2016SaleNicholas Adams200.00513,6971,027,394.00
21/06/2016SaleMr. Michael Roller200.009,62219,244.00

Company Profile

Bioquell PLC is engaged in the design, manufacture and supply of bio-decontamination and containment equipment, related products and services to the healthcare, life sciences and defence industries.
 

Sector

Medical Devices

Market Position

1214 of 1865 Companies

Index

FTSE Fledgling

Outlook

(24/08/2016) ch - "The board is confident that the improved financial performance seen in the first half of the year will carry through to the full year"

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)19.7317.2116.27
Div Yld (E)1.972.024.36
PEG (E)0.261.490.00
ROCE1.7933.3680.66
Op Mrgn3.26-26.17-14.86
EPS Grwth75.7115.6125.03
Dividends
PreviousLatest
More ...
Record Date06/06/1405/06/15
Ex-Div04/06/1404/06/15
Paid02/07/1402/07/15
Amnt3.303.30

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr Ian Johnson
Chief ExecutiveNicholas Adams
Group Finance DirectorMr. Michael Roller
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.